A1AAK
muvalaplin
| Created: | 2023-12-15 |
| Last modified: | 2024-05-08 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 106 |
| Chiral Atom Count | 6 |
| Bond Count | 111 |
| Aromatic Bond Count | 18 |
Chemical Component Summary | |
|---|---|
| Name | muvalaplin |
| Synonyms | (2S,2'S,2''S)-3,3',3''-[azaniumyltris(methylene-3,1-phenylene)]tris{2-[(3R)-pyrrolidin-1-ium-3-yl]propanoate} |
| Systematic Name (OpenEye OEToolkits) | (2~{S})-3-[3-[[bis[[3-[(2~{S})-3-oxidanyl-3-oxidanylidene-2-[(3~{R})-pyrrolidin-3-yl]propyl]phenyl]methyl]amino]methyl]phenyl]-2-[(3~{R})-pyrrolidin-3-yl]propanoic acid |
| Formula | C42 H54 N4 O6 |
| Molecular Weight | 710.901 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 12.01 | O=C(O)C(Cc1cccc(c1)CN(Cc1cccc(CC(C(=O)O)C2CCNC2)c1)Cc1cc(CC(C2CCNC2)C(=O)O)ccc1)C1CCNC1 |
| SMILES | CACTVS | 3.385 | OC(=O)[CH](Cc1cccc(CN(Cc2cccc(C[CH]([CH]3CCNC3)C(O)=O)c2)Cc4cccc(C[CH]([CH]5CCNC5)C(O)=O)c4)c1)[CH]6CCNC6 |
| SMILES | OpenEye OEToolkits | 2.0.7 | c1cc(cc(c1)CN(Cc2cccc(c2)CC(C3CCNC3)C(=O)O)Cc4cccc(c4)CC(C5CCNC5)C(=O)O)CC(C6CCNC6)C(=O)O |
| Canonical SMILES | CACTVS | 3.385 | OC(=O)[C@@H](Cc1cccc(CN(Cc2cccc(C[C@@H]([C@H]3CCNC3)C(O)=O)c2)Cc4cccc(C[C@@H]([C@H]5CCNC5)C(O)=O)c4)c1)[C@H]6CCNC6 |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | c1cc(cc(c1)CN(Cc2cccc(c2)C[C@@H]([C@H]3CCNC3)C(=O)O)Cc4cccc(c4)C[C@@H]([C@H]5CCNC5)C(=O)O)C[C@@H]([C@H]6CCNC6)C(=O)O |
| InChI | InChI | 1.06 | InChI=1S/C42H54N4O6/c47-40(48)37(34-10-13-43-22-34)19-28-4-1-7-31(16-28)25-46(26-32-8-2-5-29(17-32)20-38(41(49)50)35-11-14-44-23-35)27-33-9-3-6-30(18-33)21-39(42(51)52)36-12-15-45-24-36/h1-9,16-18,34-39,43-45H,10-15,19-27H2,(H,47,48)(H,49,50)(H,51,52)/t34-,35-,36-,37-,38-,39-/m0/s1 |
| InChIKey | InChI | 1.06 | BRLGERLDHZRETI-BGBFCPIGSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB21568 |
|---|---|
| Name | Muvalaplin |
| Groups | investigational |
| Description | Muvalaplin is a small molecule drug. Muvalaplin is under investigation in clinical trial NCT05563246 (A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events). Muvalaplin has a monoisotopic molecular weight of 710.4 Da. |
| Synonyms | Muvalaplin |
| CAS number | 2565656-70-2 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Apolipoprotein(a) | MEHKEVVLLLLLFLKSAAPEQSHVVQDCYHGDGQSYRGTYSTTVTGRTCQ... | unknown | inhibitor |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 155369486 |
| ChEMBL | CHEMBL4802585 |














